The weak-boson fusion process is expected to provide crucial information on Higgs boson couplings at the Large Hadron Collider at CERN. The achievable statistical accuracy demands comparison with next-to-leading order QCD calculations, which are presented here in the form of a fully flexible parton Monte Carlo program. QCD corrections are determined for jet distributions and are shown to be modest, of order 5 to 10% in most cases, but reaching 30% occasionally. Remaining scale uncertainties range from order 5% or less for distributions to below ±2% for the Higgs boson cross section in typical weak-boson fusion search regions.
Deviations from SM expectations in the Higgs sector can be parameterized by an effective Lagrangian. The corresponding anomalous couplings have been implemented in a Monte Carlo program for Higgs production in vector boson fusion, at NLO QCD accuracy. It allows to study anomalous coupling effects for production and decay of the Higgs boson. We analyze deviations allowed by LEP data and study a new azimuthal angle variable which directly measures the interference between CP-even, CP-odd and SM couplings.
Higgs boson production via weak boson fusion is sensitive to the tensor structure of the HV V (V = W, Z) couplings, which distinguishes loop induced vertices from SM expectations. At the CERN Large Hadron Collider this information shows up most clearly in the azimuthal angle correlations of the two forward and backward quark jets which are typical for weak boson fusion. We calculate the next-to-leading order QCD corrections to this process, in the presence of anomalous HV V couplings. Gluon emission does not significantly change the azimuthal jet correlations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.